Managing Parkinson’s disease relies heavily on restoring or mimicking the brain dopamine levels. While no medication can yet stop the underlying progression of the disease, modern pharmacology provides highly effective ways to control motor symptoms like tremors, stiffness, and slowness. The choice of medication depends on a patient age, the severity of their symptoms, and how much the condition impacts their daily life. Treatment is rarely a one size fits all approach; instead, it is a dynamic process where doses and drug combinations are carefully adjusted over time to maintain the best possible quality of life and physical independence.
What we will discuss in this article
- The primary role of Levodopa as the gold standard treatment
- How dopamine agonists mimic the effects of dopamine in the brain
- The use of MAO B and COMT inhibitors to prolong drug effectiveness
- Anticholinergics and their specific role in tremor management
- Amantadine and its use in treating involuntary movements
- Managing medication wearing off and the on off phenomenon
- Emergency guidance for severe medication reactions
Levodopa: The gold standard
Levodopa remains the most effective and widely used medication for treating the motor symptoms of Parkinson’s disease.
Levodopa is a chemical precursor that is converted into dopamine once it enters the brain. To ensure that the medication reaches the brain before being broken down in the bloodstream, it is always paired with a second drug, either carbidopa or benserazide. This combination also helps reduce systemic side effects such as nausea and dizziness. Most patients experience a dramatic improvement in mobility and a reduction in tremors shortly after starting this treatment. However, after several years of use, some patients may develop involuntary movements known as dyskinesia or find that each dose lasts for a shorter period.
Dopamine agonists
These medications do not turn into dopamine but instead act directly on the brain dopamine receptors to stimulate them.
Dopamine agonists are often used as a first line treatment in younger patients to delay the start of Levodopa or as an add on therapy in later stages. Common examples include pramipexole, ropinirole, and rotigotine, which is available as a skin patch. While they are effective at managing motor symptoms, they carry a specific risk of impulse control disorders. This can manifest as unexpected behaviours like compulsive gambling, hypersexuality, or binge eating. As a physician, I emphasize the importance of patients and their families being aware of these psychological side effects from the start of therapy.
MAO B and COMT inhibitors
These classes of medication are designed to make the brain existing or supplemental dopamine last longer by blocking the enzymes that break it down.
MAO B inhibitors
Drugs such as selegiline and rasagiline block the enzyme monoamine oxidase B. They can be used alone in the very early stages to manage mild symptoms or added to Levodopa to help smooth out the therapeutic effect. They are generally well tolerated but require a review of other medications to avoid potential drug interactions.
COMT inhibitors
Entacapone and opicapone are examples of COMT inhibitors. These are primarily used in combination with Levodopa. By blocking the COMT enzyme, they prevent Levodopa from being broken down in the body, allowing more of it to reach the brain. This is particularly helpful for patients who experience the wearing off phenomenon, where symptoms return before the next dose is due.
Other symptom specific medications
Depending on a patient specific symptom profile, other medications may be introduced to target individual issues.
| Medication Type | Common Examples | Primary Use |
| Anticholinergics | Trihexyphenidyl, Procyclidine | Specifically used to reduce severe tremors |
| Amantadine | Symmetrel | Used to treat dyskinesia |
| Adenosine Antagonists | Istradefylline | An add on to Levodopa to reduce off periods |
Anticholinergics are used less frequently today, especially in older patients, because they can cause significant side effects like confusion, blurred vision, and dry mouth. Amantadine is often introduced later in the disease course if the involuntary movements caused by long term Levodopa use become bothersome.
Managing medication fluctuations
As Parkinson’s progresses, the brain ability to store dopamine diminishes, leading to fluctuations in how well the medicine works throughout the day.
This is often referred to as the on off phenomenon. Being on means the medication is working well and movement is relatively fluid. Being off means the medication has worn off, and symptoms like stiffness and tremor return. To manage this, doctors may suggest taking smaller doses of Levodopa more frequently, using controlled release versions, or adding a COMT inhibitor to extend the duration of each dose. Keeping a detailed diary of when symptoms return can help your neurology team fine tune your medication schedule.
Emergency guidance
While Parkinson’s medications are life changing, sudden changes to your regime or severe reactions require urgent medical attention.
If you experience a sudden total inability to move or a high fever with extreme muscle stiffness, seek immediate medical help.
Seek urgent medical help if you notice:
- Severe confusion, vivid hallucinations, or signs of delirium
- Rapid heart rate combined with severe muscle rigidity
- Signs of a severe allergic reaction such as swelling of the face or tongue
- Acute fainting or very low blood pressure when standing
- Sudden and intense changes in behaviour or mood that pose a risk to safety
To summarise
Pharmacological treatment for Parkinson’s disease is highly effective at managing motor symptoms and improving daily function. Levodopa remains the most powerful tool available, supported by dopamine agonists and enzyme inhibitors that help maintain stable dopamine levels. Because the disease is progressive, medication plans must be reviewed and adjusted regularly by a specialist. By understanding how these different drug classes work and being aware of potential side effects like dyskinesia or impulse control issues, patients can work effectively with their healthcare team to find the most balanced and beneficial treatment strategy.
Can I stop my Parkinson’s medication if I feel better?
No. Suddenly stopping your medication can be very dangerous and may lead to a life threatening condition called Neuroleptic Malignant Syndrome. Always talk to your doctor before changing your dose.
How long does it take for Levodopa to start working?
Most people notice an improvement within a few days to a week of reaching an effective dose, though it can take longer for the full benefits to be realized.
Why do I have to take my pills so precisely on time?
Consistent timing ensures a steady level of dopamine in your brain. Missing a dose by even 30 minutes can cause symptoms to return or lead to a difficult off period.
Are there medications for non motor symptoms?
Yes. Different medicines can be prescribed specifically for issues like depression, anxiety, sleep problems, and constipation, which are not treated by dopamine replacement alone.
Does protein interfere with my medication?
In some patients, high protein meals can interfere with the absorption of Levodopa. If you notice your medication is less effective after eating, your doctor may suggest taking it 30 to 60 minutes before meals.
What is dyskinesia?
These are involuntary, often flowing or jerky movements that can occur as a side effect of long term Levodopa use. They are different from the Parkinson’s tremor itself.
Can these medicines cure Parkinson’s?
Currently, medications only manage the symptoms. They do not stop the underlying loss of nerve cells, but they significantly improve quality of life for many years.
Authority Snapshot
This article was reviewed by Dr. Stefan Petrov, a UK trained physician with an MBBS and postgraduate certifications in Basic and Advanced Life Support. He has extensive experience in general medicine, surgery, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units and is dedicated to medical education, helping patients understand the complexities of pharmacological management in chronic neurological conditions.
